안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling.
Bhattiprolu AK, Kollipara S, Boddu R, Ahmed T. (2024) Xenobiotica. Oct 14:1-15
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, bioequivalence trials, vbe, dissolution specifications, safe space
A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: Methodologies, case studies and way forward.
Chougule M, Kollipara S, Mondal S, Ahmed T. (2024) Eur J Clin Pharmacol. Oct 8
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, bioequivalence trials, vbe, population simulations, special populations, disease state
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human.
Salphati L, Pang J, Plise EG, Cheong J, Braun MG, Friedman LS, Hong Thibodeau R, Jaochico A, Johnson R, Liu N, Nannini M, Sampath D, Song K, Hannan EJ, Staben ST. (2024) Xenobiotica. Oct 10:1-20
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, first in human, fih, dose selection, dose optimization, translational science
Bioequivalence Requirements for Orally Inhaled and Nasal Drug Products and Use of Novel Physiologically Based Biopharmaceutics Modeling Approaches for Assessing In Vivo Performance.
Rachapally A, Boddu R, Kollipara S, Ahmed T. (2024) J Pharm Sci. Oct 14:S0022-3549(24)00440-4
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, additional dosage routes, pulmonary, intranasal, bioequivalence studies, vbe, pcat
Hansen parameters and GastroPlus assisted optimized topical elastic liposomes to treat breast cancer using a novel isatin derivative.
Altamimi MA, Hussain A, Alanazi MM, Alotaibi D, Saeed S, Bari A. (2024) Arabian J Chemistry Oct 18
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, formulation assessment, risk assessment, mechanistic absorption
안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling.
Bhattiprolu AK, Kollipara S, Boddu R, Ahmed T. (2024) Xenobiotica. Oct 14:1-15
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, bioequivalence trials, vbe, dissolution specifications, safe space
A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: Methodologies, case studies and way forward.
Chougule M, Kollipara S, Mondal S, Ahmed T. (2024) Eur J Clin Pharmacol. Oct 8
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, bioequivalence trials, vbe, population simulations, special populations, disease state
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human.
Salphati L, Pang J, Plise EG, Cheong J, Braun MG, Friedman LS, Hong Thibodeau R, Jaochico A, Johnson R, Liu N, Nannini M, Sampath D, Song K, Hannan EJ, Staben ST. (2024) Xenobiotica. Oct 10:1-20
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, first in human, fih, dose selection, dose optimization, translational science
Bioequivalence Requirements for Orally Inhaled and Nasal Drug Products and Use of Novel Physiologically Based Biopharmaceutics Modeling Approaches for Assessing In Vivo Performance.
Rachapally A, Boddu R, Kollipara S, Ahmed T. (2024) J Pharm Sci. Oct 14:S0022-3549(24)00440-4
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, additional dosage routes, pulmonary, intranasal, bioequivalence studies, vbe, pcat
Hansen parameters and GastroPlus assisted optimized topical elastic liposomes to treat breast cancer using a novel isatin derivative.
Altamimi MA, Hussain A, Alanazi MM, Alotaibi D, Saeed S, Bari A. (2024) Arabian J Chemistry Oct 18
Keywords: gastroplus, pbpk modeling, physiologically based biopharmaceutics, pbbm, formulation assessment, risk assessment, mechanistic absorption